Company intelligence / Profile preview

Aesculape

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Aesculape CRO provides full clinical research services, including Phase I-IV trials, trial design, data management and analysis. They specialize in coordinating multi-center and international trials, particularly in oncology and metabolic trials. They also have experience in trials with medical devices and biosimilars.

Therapeutic areas: OncologyMetabolic Disorders
Industry: Contract Research Organization

Beyond the preview

Go deeper on Aesculape.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aesculape.

Explore the full profile